Table_4_Retrospective investigation of the origin and epidemiology of the dengue outbreak in Yunnan, China from 2017 to 2018.DOCX by Liang Cao (135383)

“…<p>Since 2013, a dengue epidemic has broken out in Yunnan, China and neighboring countries. …”

Table_3_Retrospective investigation of the origin and epidemiology of the dengue outbreak in Yunnan, China from 2017 to 2018.DOCX by Liang Cao (135383)

“…<p>Since 2013, a dengue epidemic has broken out in Yunnan, China and neighboring countries. …”

Table_2_Retrospective investigation of the origin and epidemiology of the dengue outbreak in Yunnan, China from 2017 to 2018.DOCX by Liang Cao (135383)

“…<p>Since 2013, a dengue epidemic has broken out in Yunnan, China and neighboring countries. …”

Table_1_Retrospective investigation of the origin and epidemiology of the dengue outbreak in Yunnan, China from 2017 to 2018.DOCX by Liang Cao (135383)

“…<p>Since 2013, a dengue epidemic has broken out in Yunnan, China and neighboring countries. …”

Supplementary Material for: Prediction of Therapeutic Response Using Contrast-Enhanced Ultrasound in Japanese Patients Treated with Atezolizumab and Bevacizumab for Unresectable He... by Takada H. (11871941)

“…Cases without decreased blood flow in TIC analysis (<i>n</i> = 10) had more cases with PD compared with cases with decreased blood flow (60 vs. 0%, <i>p</i> = 0.001). …”

Table_1_Clinical and genetic characteristics of BAP1-mutated non-uveal and uveal melanoma.docx by Johanna Matull (18767917)

“…GNAQ and GNA11 mutations were common in uveal melanomas, while MAP-Kinase mutations were frequent in non-uveal melanomas with NF1, BRAF V600 and NRAS Q61 mutations occurring in decreasing frequency, consistent with a strong UV association. …”

Data_Sheet_1_Cost-effectiveness of ensartinib, crizotinib, ceritinib, alectinib, brigatinib and lorlatinib in patients with anaplastic lymphoma kinase-positive non-small cell lung... by Xia Luo (169127)

“…When compared with lorlatinib and alectinib, ensartinib was associated with a lower QALY and decreased total costs; the ICERs for lorlatinib and alectinib were $934,101/ QALY and $164,888/ QALY, respectively.…”

VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma. by Martini, Maurizio

Get full text
Get full text

Subclinical ketosis risk prediction in dairy cows based on prepartum metabolic indices by D. Wang (727618)

Moving Through: Tracking PhD students’ experiences of COVID by Andrea Stein (11001303)

Supplementary Material for: Loss of MD1 promotes inflammatory and apoptotic atrial remodelling in diabetic cardiomyopathy by activating the TLR4/NF-κB signalling pathway by Shi T. (11781503)

Data.zip by Quan Wang (11412221)

Influence of strawberry jam color and phenolic compounds on acceptance during storage by Lívia de Lacerda de Oliveira Pineli (12689161)

Potassium sources and doses in coriander fruit production and essential oil content by Marta Simone Mendonça Freitas (5555051)

Supplementary Material for: Relaxing Effect of TSU-68, an Antiangiogenic Agent, on Mouse Airway Smooth Muscle by Tan H. (2850323)

Supplementary Material for: Tranexamic Acid Protects Ovary and Testis Functions and Ameliorates Osteoporosis in Mice by Hiramoto K. (8779754)

Dynamics of land use and land cover change in the distal Okavango Delta, Botswana by Reniko Gondo (19458227)

Supplementary Material for: Mycobacteria Manipulate G-Protein-Coupled Receptors to Increase Mucosal Rac1 Expression in the Lungs by Alaridah N. (3601412)

The relationship between apathy and nonparametric variables of rest activity rhythm in older adults with cerebral small vessel disease by Hongyi Zhao (3938498)

Mediterranean Y-chromosome 2.0—why the Y in the Mediterranean is still relevant in the postgenomic era by Maarten H. D. Larmuseau (655788)